Total Knee Arthroplasty - Market Insights, Competitive Landscape, and Market Forecast - 2034

Total Knee Arthroplasty Market Summary

Overview:

• The Total Knee Arthroplasty market is estimated at USD 10.90 billion in 2025 and is projected to reach USD 17.65 billion by 2034. Growth is anchored in the rising burden of knee osteoarthritis in an aging population, the rapid adoption of robotic-assisted and digitally enabled surgery, and the migration of knee replacement procedures into ambulatory surgical centers.
• The global Total Knee Arthroplasty market is growing at a CAGR of 5.5% during the forecast period from 2026 to 2034.
• By procedure type, the total knee replacement segment dominated the Total Knee Arthroplasty market with an 82% share in 2025.
• By implant fixation type, the cemented segment dominated the Total Knee Arthroplasty market with a 69% share in 2025.
• By material type, the metal alloys segment dominated the Total Knee Arthroplasty market with a 54% share in 2025.
• By implant component, the femoral components segment dominated the Total Knee Arthroplasty market with a 36% share in 2025.
• By indication, the osteoarthritis segment dominated the Total Knee Arthroplasty market with an 87% share in 2025.
• By end user, the hospitals segment dominated the Total Knee Arthroplasty market with a 71% share in 2025.
• North America dominated the global Total Knee Arthroplasty market revenue with a 41% share in 2025, representing the highest regional market share globally.

Total knee arthroplasty (TKA), also known as total knee replacement, is a surgical procedure in which the damaged articulating surfaces of the knee joint are removed and replaced with prosthetic implants to relieve pain, correct deformity, and restore mobility in patients whose joint disease has not responded to conservative care. A knee arthroplasty system typically combines a femoral component, a tibial component (tray), a tibial insert (bearing), and, in many cases, a patellar component, secured to bone with bone cement, through biological ingrowth into porous surfaces, or through a hybrid of the two. These implants are manufactured from cobalt-chromium and titanium alloys, highly cross-linked and antioxidant-stabilized polyethylene, ceramic and ceramic-coated metals, and oxidized zirconium, and are increasingly delivered with robotic, navigation, and patient-specific planning technologies. The market is organized by procedure type across total, partial, and revision knee replacement; by implant fixation type across cemented, cementless, and hybrid; by material type; by implant component; by indication, led by osteoarthritis; and by end user across hospitals, ambulatory surgical centers, and orthopedic specialty clinics. Driven by population aging, the high prevalence of osteoarthritis and obesity, the rapid adoption of robotics and cementless fixation, and favorable reimbursement for outpatient joint replacement, total knee arthroplasty has become one of the highest-volume and most commercially significant procedures in orthopedics.

Total Knee Arthroplasty Market Key Growth Drivers

• The rising prevalence of osteoarthritis in an aging global population is expanding the pool of patients eligible for knee replacement, with the United States alone performing more than 790,000 total knee replacements each year according to the American Academy of Orthopaedic Surgeons.
• Rapid adoption of robotic-assisted and digitally enabled surgery is reshaping the market, with Stryker's Mako platform used in over 2 million procedures across 46 countries and new handheld and enhanced systems launching in 2025 and 2026.
• The migration of knee replacement into ambulatory surgical centers, supported by Medicare reimbursement and the removal of total knee arthroplasty from the inpatient-only list, is lowering cost and expanding procedure capacity.
• Advances in implant design and materials, including 3D-printed porous cementless components, highly cross-linked polyethylene, and ceramic-coated and oxidized zirconium surfaces, are improving longevity and widening the eligible patient population.
• A growing revision burden and the demand from younger, more active, and more obese patients are increasing demand for durable primary implants and complex revision and hinge systems.
• Supportive regulatory momentum, including recent FDA clearances for next-generation knee systems and robotic platforms, is accelerating product turnover and technology refresh cycles.
• The convergence of demographic demand, robotics-led technology cycles, outpatient migration, and active strategic investment is expected to sustain steady mid-single-digit growth in the market through 2034.

Key Companies in Total Knee Arthroplasty Market

The competitive landscape is led by the following active orthopedic implant manufacturers and technology providers:

• Zimmer Biomet
• Stryker Corporation
• DePuy Synthes (Johnson & Johnson)
• Smith+Nephew
• Enovis Corporation
• Medacta International
• B. Braun (Aesculap)
• MicroPort Orthopedics
• Exactech
• Corin Group

Factors Contributing to the Growth of the Total Knee Arthroplasty Market

Market Drivers

Rising Prevalence of Osteoarthritis and Population Aging

The most powerful driver of the Total Knee Arthroplasty market is the rising prevalence of knee osteoarthritis in an aging, increasingly overweight global population. A Global Burden of Disease analysis published in The Lancet Rheumatology estimated that approximately 595 million people were living with osteoarthritis worldwide in 2020 and projected the figure to approach 1 billion by 2050, with the knee the most commonly affected large joint. In the United States, the American Academy of Orthopaedic Surgeons reports that more than 790,000 total knee replacements are performed annually. As conservative options such as physical therapy, weight management, injections, and analgesics lose effectiveness in advanced disease, knee replacement remains the definitive and highly cost-effective treatment. Longer life expectancy, higher obesity rates, and patient expectations of an active lifestyle are pushing the treated population younger and larger, directly expanding procedure volumes and implant demand through 2034.

Expansion of Robotic-Assisted and Digitally Enabled Surgery

Robotics and enabling technologies have become a central competitive and growth lever in knee arthroplasty. Stryker's Mako platform has been used in more than 2 million procedures across 46 countries, and in 2026 the company moved from a limited release in February to a full U.S. commercial launch in July of Mako RPS, a handheld robotic system for total knee that pairs with the Triathlon implant. Zimmer Biomet received FDA 510(k) clearance in November 2025 for ROSA Knee with OptiMiZe, with commercial availability in the United States expected in the first quarter of 2026, while Smith+Nephew's CORI handheld robotics platform underpins its newly cleared LANDMARK Total Knee System. Robotic and navigation systems tie surgeons to a manufacturer's implant ecosystem, support personalized and kinematic alignment, and generate recurring implant and disposable revenue, reinforcing growth in premium implant demand.

Market Restraints

Despite steady momentum, the Total Knee Arthroplasty market faces material constraints. The high cost of implants, robotic systems, and enabling technologies places pressure on hospital and ASC budgets, and capital-intensive robotic platforms can be difficult for smaller facilities to justify. Government pricing interventions have compressed implant revenue in important markets, including China's national volume-based procurement program for artificial joints, which sharply reduced knee implant prices, and India's price caps on knee implants introduced in 2017. Surgical risks, including infection, aseptic loosening, stiffness, and implant wear, along with the need for revision surgery, create clinical and economic burdens, and historical recalls, such as polyethylene insert recalls affecting certain knee systems, have shown how quality events can damage manufacturer reputations and market share. Stringent and evolving regulatory requirements, including the European Union Medical Device Regulation, raise compliance costs and lengthen timelines, while long surgical learning curves for robotic and kinematic alignment techniques and a shortage of orthopedic surgeons and operating-room capacity in many regions limit throughput. Reimbursement pressure from payers, bundled payment models, and lengthy waiting lists in publicly funded systems constrain procedure volumes, and trade tariffs and supply chain disruptions add cost and uncertainty. Together, these pricing, clinical, regulatory, workforce, and supply barriers temper the pace of growth, even as the underlying drivers of demographic demand, robotics-led innovation, and outpatient migration remain firmly intact.

Total Knee Arthroplasty Market Segment Analysis

The Total Knee Arthroplasty Market is segmented by procedure type (total knee replacement, partial knee replacement, revision knee replacement), implant fixation type (cemented, cementless, hybrid), material type (metal alloys, polyethylene, ceramic, oxidized zirconium, ceramic-coated metals), implant component (femoral components, tibial components, patellar components, tibial inserts), indication (osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, other degenerative joint diseases), end user (hospitals, ambulatory surgical centers, orthopedic specialty clinics), and geography (North America, Europe, Asia-Pacific, Rest of World).

By Procedure Type

Dominant Subsegment: Total Knee Replacement.

The total knee replacement segment accounted for 82% of the Total Knee Arthroplasty market in 2025. Total knee replacement is the leading procedure type because it is the definitive treatment for advanced tricompartmental knee disease, which is the most common presentation of osteoarthritis, and because it carries the largest implant content and the highest average selling price of any knee procedure. The procedure benefits from decades of clinical evidence, well-established surgical technique, and strong registry-backed survivorship, and it is the primary use case for robotic platforms such as Mako, ROSA, VELYS, and CORI. High procedure volumes in the United States, Europe, and a growing share of Asia-Pacific sustain recurring demand. Partial knee replacement is growing as a bone-preserving option for isolated compartment disease, supported by innovations such as cementless partial implants, while revision knee replacement is the fastest-growing procedure type as the installed base of implants ages. Nonetheless, the scale of primary total knee procedures secures the segment's leadership across the forecast period.

By Implant Fixation Type

Dominant Subsegment: Cemented.

The cemented segment accounted for 69% of the Total Knee Arthroplasty market in 2025. Cemented fixation is the leading approach because it is the long-established gold standard, supported by extensive registry data showing reliable long-term survivorship, and because it performs predictably across a wide range of bone quality, including the osteoporotic bone commonly seen in older patients. Surgeons are familiar with cemented technique, and most widely used knee systems were developed and validated with cement. Cementless fixation is the fastest-growing category, driven by 3D-printed porous titanium surfaces, advanced coatings, shorter operative time, and growing use in younger, active patients and in ASC workflows, with manufacturers expanding cementless offerings across total and partial knee systems. Hybrid fixation, typically a cementless femur with a cemented tibia, offers a middle path. While cementless adoption is accelerating, the entrenched evidence base, surgeon familiarity, and reliability of cemented fixation secure its leadership across the forecast period.

Total Knee Arthroplasty Market Region Analysis

Dominant Region: North America

North America accounted for 41% of the global Total Knee Arthroplasty market revenue in 2025, representing the highest regional market share globally. The region's dominance reflects high procedure volumes, with the United States performing more than 790,000 total knee replacements each year, a high prevalence of osteoarthritis and obesity, strong reimbursement, and early, widespread adoption of robotic-assisted surgery and premium implants. North America is home to the headquarters and principal operations of leading manufacturers, including Zimmer Biomet in Warsaw, Indiana, and Stryker in Portage, Michigan, and it is the first market for most new product launches, including recent introductions of Mako RPS, ROSA Knee with OptiMiZe, and the LANDMARK Total Knee System. Favorable Medicare coverage across inpatient, outpatient, and ASC settings is accelerating outpatient migration, while a dense network of high-volume orthopedic centers and robust FDA pathways supports rapid technology uptake. Strong reimbursement, regulatory clarity, and technology leadership anchor the region's continued leadership across the forecast period.

Fastest Growing Region: Asia-Pacific

Asia-Pacific is the fastest-growing region in the Total Knee Arthroplasty market. The region's elevated CAGR is driven by rapidly aging populations, rising osteoarthritis and obesity prevalence, expanding access to orthopedic care, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China's national volume-based procurement has lowered implant prices and broadened access, stimulating procedure volumes and favoring scaled domestic and multinational suppliers, while Japan's super-aged society sustains strong demand for joint replacement. India benefits from a large patient base, growing private hospital capacity, and regulated implant pricing that improves affordability, and South Korea and Australia are advanced markets with high adoption of robotics. Rising medical tourism, growing health insurance coverage, and the expansion of domestic manufacturers such as MicroPort Orthopedics are accelerating adoption. The combination of demographic pressure, access expansion, and technology adoption positions Asia-Pacific as the principal source of incremental growth over the forecast period.

Regional Commentary

North America

North America accounted for 41% of the global Total Knee Arthroplasty market revenue in 2025. The United States dominates on the strength of its procedure volumes, favorable reimbursement, early robotics adoption, ASC migration, and the presence of leading manufacturers, while Canada and Mexico contribute steady growth through expanding access and medical tourism.

Europe

Europe is a large and mature regional market, supported by aging populations, universal healthcare systems, and long-established national joint registries such as the National Joint Registry in the United Kingdom and the Swedish and German registries that inform implant selection. The region is home to leading orthopedic companies, including Smith+Nephew in the United Kingdom, Medacta in Switzerland, B. Braun (Aesculap) in Germany, and Corin Group in the United Kingdom, and procedure demand is strong across Germany, France, the United Kingdom, Italy, and Spain, although the European Union Medical Device Regulation and tender-based purchasing add compliance and pricing pressure.

Asia-Pacific

Asia-Pacific is the fastest-growing region, propelled by rapidly aging populations, rising osteoarthritis incidence, expanding access to orthopedic surgery, and growing healthcare investment across China, Japan, India, South Korea, and Australia. China's volume-based procurement, Japan's super-aged demographics, India's regulated implant pricing and private hospital growth, and the rise of regional manufacturers are accelerating adoption and procedure volumes.

Rest of World

The Rest of World region, spanning Latin America, the Middle East, and Africa, is an emerging growth frontier. Expanding private hospital networks, rising incomes and insurance coverage, growing medical tourism, and increasing orthopedic surgical capacity are gradually broadening access to knee replacement, while price sensitivity and uneven reimbursement continue to shape the pace of adoption.

Total Knee Arthroplasty Market Competitive Landscape

The Total Knee Arthroplasty market is classified as Moderately Concentrated. A group of global leaders with broad implant portfolios, robotic ecosystems, and extensive surgeon relationships, including Zimmer Biomet, Stryker Corporation, DePuy Synthes (Johnson & Johnson), and Smith+Nephew, anchors the top tier and together controls roughly 71% of worldwide joint replacement sales, while fast-growing challengers and specialists such as Enovis Corporation, Medacta International, B. Braun (Aesculap), MicroPort Orthopedics, Exactech, and Corin Group compete through differentiated implant designs, kinematic alignment, navigation and robotics, and regional strength, increasing competition in the fastest-growing segments.

The competitive landscape can be evaluated across the following dimensions:

• Market concentration: Moderately concentrated, with four global leaders anchoring the top tier and a growing field of challengers and regional specialists.
• Leading players: Zimmer Biomet, Stryker, DePuy Synthes, and Smith+Nephew anchor the top tier through broad portfolios, installed robotic bases, and surgeon relationships.
• Geographic reach: Leaders operate global sales and distribution networks; Stryker's Mako platform is used in more than 45 countries, and challengers such as Medacta, MicroPort, and Corin extend reach through regional strength.
• Product portfolio strength: Top players offer primary, partial, and revision knee systems across fixation types and bearing options, supported by instrumentation and digital planning tools.
• Robotics and enabling technology: Integrated robotic, navigation, and planning ecosystems, including Mako, ROSA, VELYS, CORI, and ARVIS, are a decisive advantage that ties surgeons to implant platforms.
• Strategic partnerships: Collaborations such as Zimmer Biomet's partnership with THINK Surgical and surgeon-developer co-design programs extend technology reach.
• M&A activity: Active consolidation, including Zimmer Biomet's acquisition of Monogram Technologies, Enovis' acquisition of LimaCorporate, and Johnson & Johnson's planned separation of DePuy Synthes.
• Manufacturing capabilities: Additive manufacturing of porous titanium and 3D-printed components, advanced polyethylene processing, and ceramic and oxidized zirconium surface technologies are key competitive moats.
• Innovation focus: Handheld and autonomous robotics, personalized and kinematic alignment, cementless fixation, ASC-optimized systems, and data-driven outcomes tracking.

Total Knee Arthroplasty Market Recent Developmental Activities

In September 2026, Smith+Nephew received FDA 510(k) clearance for its LANDMARK Total Knee System and completed the first surgical cases, an anatomy-driven system featuring a fully 3D-printed femoral component designed for use with the CORI KNEE handheld robotics platform, with broader commercial availability expected throughout 2027. Strategic significance: Refreshes Smith+Nephew's knee franchise with a differentiated implant and strengthens its hospital and ASC robotics proposition.

In July 2026, Stryker Corporation announced the full U.S. commercial launch of Mako RPS (Robotic Power System) for total knee replacement, introducing Mako Handheld Robotics alongside Mako SmartRobotics with Mako 4 and compatible with the Triathlon Total Knee System. Strategic significance: Extends Mako to a new segment of surgeons and care settings and deepens implant platform loyalty.

Total Knee Arthroplasty Market Segmentation

Total Knee Arthroplasty Market by Procedure Type

• Total Knee Replacement
• Partial Knee Replacement
• Revision Knee Replacement

Total Knee Arthroplasty Market by Implant Fixation Type

• Cemented
• Cementless
• Hybrid

Total Knee Arthroplasty Market by Material Type

• Metal Alloys
• Polyethylene
• Ceramic
• Oxidized Zirconium
• Ceramic-Coated Metals

Total Knee Arthroplasty Market by Implant Component

• Femoral Components
• Tibial Components
• Patellar Components
• Tibial Inserts

Total Knee Arthroplasty Market by Indication

• Osteoarthritis
• Rheumatoid Arthritis
• Post-Traumatic Arthritis
• Other Degenerative Joint Diseases

Total Knee Arthroplasty Market by End User

• Hospitals
• Ambulatory Surgical Centers
• Orthopedic Specialty Clinics

Total Knee Arthroplasty Market by Geography

• North America Total Knee Arthroplasty Market
• United States Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Canada Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Mexico Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Europe Total Knee Arthroplasty Market
• Germany Total Knee Arthroplasty Market Size in USD million (2023-2034)
• United Kingdom Total Knee Arthroplasty Market Size in USD million (2023-2034)
• France Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Italy Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Spain Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Rest of Europe Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Asia-Pacific Total Knee Arthroplasty Market
• China Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Japan Total Knee Arthroplasty Market Size in USD million (2023-2034)
• India Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Australia Total Knee Arthroplasty Market Size in USD million (2023-2034)
• South Korea Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Rest of Asia-Pacific Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Rest of the World (RoW) Total Knee Arthroplasty Market
• Middle East Total Knee Arthroplasty Market Size in USD million (2023-2034)
• Africa Total Knee Arthroplasty Market Size in USD million (2023-2034)
• South America Total Knee Arthroplasty Market Size in USD million (2023-2034)

Key Takeaways from the Total Knee Arthroplasty Market Report Study

• Market size analysis for the current total knee arthroplasty market size (2025), and market forecast for 9 years (2026 to 2034).
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures that happened over the last 3 years.
• Key companies dominating the global total knee arthroplasty market.
• Various opportunities available for competitors in the total knee arthroplasty market space.
• What are the top-performing segments in 2025? How will these segments perform in 2034?
• Which are the top-performing regions and countries in the current total knee arthroplasty market scenario?
• Which are the regions and countries where companies should concentrate their opportunities for total knee arthroplasty market growth in the future?

Target audience who can benefit from this total knee arthroplasty market report study

• Total knee arthroplasty implant manufacturers and product providers
• Research organizations and consulting companies
• Total knee arthroplasty-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in knee implants and orthopedic robotics
• Various end-users, including hospitals, ambulatory surgical centers, and orthopedic specialty clinics, who want to know more about the total knee arthroplasty market and the latest technological developments in the total knee arthroplasty market.

Frequently Asked Questions:

Q1. What is the growth rate of the Total Knee Arthroplasty market?

The Total Knee Arthroplasty market is projected to expand at a CAGR of 5.5% during the forecast period from 2026 to 2034.

Q2. What is the market size of the Total Knee Arthroplasty market?

The Total Knee Arthroplasty market is estimated at USD 10.90 billion in 2025 and is projected to reach USD 17.65 billion by 2034.

Q3. Which region dominates the Total Knee Arthroplasty market?

North America dominated the Total Knee Arthroplasty market with a 41% share of global revenue in 2025, supported by high procedure volumes, a high prevalence of osteoarthritis and obesity, favorable reimbursement, early adoption of robotic-assisted surgery, and the presence of leading manufacturers. Asia-Pacific is the fastest-growing region over the forecast period.

Q4. What are the key drivers of the Total Knee Arthroplasty market?

The principal drivers are the rising prevalence of osteoarthritis in an aging population, with more than 790,000 total knee replacements performed annually in the United States; the rapid adoption of robotic-assisted and digitally enabled surgery; the migration of knee replacement to ambulatory surgical centers; advances in implant materials, cementless fixation, and 3D-printed designs; and supportive regulatory momentum and strategic investment.

Q5. Who are the major players in the Total Knee Arthroplasty market?

The major players include Zimmer Biomet, Stryker Corporation, DePuy Synthes (Johnson & Johnson), Smith+Nephew, Enovis Corporation, Medacta International, B. Braun (Aesculap), MicroPort Orthopedics, Exactech, and Corin Group, among other active providers profiled in the Competitive Landscape section, along with Waldemar Link, Kyocera Medical, and United Orthopedic. Zimmer Biomet, Stryker, DePuy Synthes, and Smith+Nephew lead through broad portfolios, robotics ecosystems, and global reach.